In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37782921.
- Also identified by DOI 10.7326/J23-0072.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chen HS, Cui Y, Zhou ZH, et al; ARAMIS Investigators. <b>Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial.</b> JAMA. 2023;329:2135-2144. 37367978.
Medical subject headings
- Ischemic Stroke